25311924|t|Genetics of Alzheimer's disease.
25311924|a|Alzheimer's disease (AD) represents the main form of dementia, and is a major public health problem. Despite intensive research efforts, current treatments have only marginal symptomatic benefits and there are no effective disease-modifying or preventive interventions. AD has a strong genetic component, so much research in AD has focused on identifying genetic causes and risk factors. This chapter will cover genetic discoveries in AD and their consequences in terms of improved knowledge regarding the disease and the identification of biomarkers and drug targets. First, we will discuss the study of the rare early-onset, autosomal dominant forms of AD that led to the discovery of mutations in three major genes, APP, PSEN1, and PSEN2. These discoveries have shaped our current understanding of the pathophysiology and natural history of AD as well as the development of therapeutic targets and the design of clinical trials. Then, we will explore linkage analysis and candidate gene approaches, which identified variants in Apolipoprotein E (APOE) as the major genetic risk factor for late-onset, "sporadic" forms of AD (LOAD), but failed to robustly identify other genetic risk factors, with the exception of variants in SORL1. The main focus of this chapter will be on recent genome-wide association studies that have successfully identified common genetic variations at over 20 loci associated with LOAD outside of the APOE locus. These loci are in or near-novel AD genes including BIN1, CR1, CLU, phosphatidylinositol-binding clathrin assembly protein (PICALM), CD33, EPHA1, MS4A4/MS4A6, ABCA7, CD2AP, SORL1, HLA-DRB5/DRB1, PTK2B, SLC24A4-RIN3, INPP5D, MEF2C, NME8, ZCWPW1, CELF1, FERMT2, CASS4, and TRIP4 and each has small effects on risk of AD (relative risks of 1.1-1.3). Finally, we will touch upon the ongoing effort to identify less frequent and rare variants through whole exome and whole genome sequencing. This effort has identified two novel genes, TREM2 and PLD3, and shown a role for APP in LOAD. The identification of these recently identified genes has implicated previously unsuspected biological pathways in the pathophysiology of AD. 
25311924	12	31	Alzheimer's disease	Disease	MESH:D000544
25311924	33	52	Alzheimer's disease	Disease	MESH:D000544
25311924	54	56	AD	Disease	MESH:D000544
25311924	86	94	dementia	Disease	MESH:D003704
25311924	303	305	AD	Disease	MESH:D000544
25311924	358	360	AD	Disease	MESH:D000544
25311924	468	470	AD	Disease	MESH:D000544
25311924	688	690	AD	Disease	MESH:D000544
25311924	757	762	PSEN1	Gene	5663
25311924	768	773	PSEN2	Gene	5664
25311924	877	879	AD	Disease	MESH:D000544
25311924	1064	1080	Apolipoprotein E	Gene	348
25311924	1082	1086	APOE	Gene	348
25311924	1157	1159	AD	Disease	MESH:D000544
25311924	1161	1165	LOAD	Disease	MESH:D000544
25311924	1262	1267	SORL1	Gene	6653
25311924	1442	1446	LOAD	Disease	MESH:D000544
25311924	1462	1466	APOE	Gene	348
25311924	1506	1508	AD	Disease	MESH:D000544
25311924	1525	1529	BIN1	Gene	274
25311924	1531	1534	CR1	Gene	1378
25311924	1536	1539	CLU	Gene	1191
25311924	1541	1595	phosphatidylinositol-binding clathrin assembly protein	Gene	8301
25311924	1597	1603	PICALM	Gene	8301
25311924	1606	1610	CD33	Gene	945
25311924	1612	1617	EPHA1	Gene	2041
25311924	1619	1624	MS4A4	Gene	83661
25311924	1625	1630	MS4A6	Gene	64231
25311924	1632	1637	ABCA7	Gene	10347
25311924	1639	1644	CD2AP	Gene	23607
25311924	1646	1651	SORL1	Gene	6653
25311924	1653	1661	HLA-DRB5	Gene	3127
25311924	1662	1666	DRB1	Gene	3123
25311924	1668	1673	PTK2B	Gene	2185
25311924	1675	1682	SLC24A4	Gene	123041
25311924	1683	1687	RIN3	Gene	79890
25311924	1689	1695	INPP5D	Gene	3635
25311924	1697	1702	MEF2C	Gene	4208
25311924	1704	1708	NME8	Gene	51314
25311924	1710	1716	ZCWPW1	Gene	55063
25311924	1718	1723	CELF1	Gene	10658
25311924	1725	1731	FERMT2	Gene	10979
25311924	1733	1738	CASS4	Gene	57091
25311924	1744	1749	TRIP4	Gene	9325
25311924	1788	1790	AD	Disease	MESH:D000544
25311924	2004	2009	TREM2	Gene	54209
25311924	2014	2018	PLD3	Gene	23646
25311924	2048	2052	LOAD	Disease	MESH:D000544
25311924	2192	2194	AD	Disease	MESH:D000544
25311924	Association	MESH:D000544	1378
25311924	Association	MESH:D000544	2041
25311924	Association	MESH:D000544	23646
25311924	Association	MESH:D000544	8301
25311924	Association	MESH:D000544	945
25311924	Association	MESH:D000544	4208
25311924	Association	MESH:D000544	23607
25311924	Association	MESH:D000544	274
25311924	Association	MESH:D000544	64231
25311924	Association	MESH:D000544	3123
25311924	Association	MESH:D000544	5663
25311924	Association	MESH:D000544	10347
25311924	Association	MESH:D000544	123041
25311924	Association	MESH:D000544	79890
25311924	Association	MESH:D000544	5664
25311924	Association	MESH:D000544	2185
25311924	Association	MESH:D000544	348
25311924	Association	MESH:D000544	3635
25311924	Association	MESH:D000544	1191
25311924	Association	MESH:D000544	10658
25311924	Association	MESH:D000544	54209
25311924	Association	MESH:D000544	83661
25311924	Association	MESH:D000544	3127

